Dr. Stan Kutcher, a co-author of a widely disseminated–now discredited ghostwritten report–“Study 329”–who ran for Canadian Parliament, The Coast, a small Canadian newspaper, retracted and then apologized for a story that highlighted about the benefits of the antidepressant, Paxil, for children.
professor of psychiatry who penned his name to aghostwritten reportRead More
Project on Government Oversight (POGO) asked NIH Director to take a firm stance against ghostwriting by academics who receive taxpayer funded grants.Read More
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?Read More
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.Read More
The FDA expanded approval process for toxic drugs is unaffected by evidence uncovered by the US Justice Department showing the studies to be flawed, if not fraudulent.Read More
"JAMA, your integrity is at stake." Chicago TribuneRead More
"The Alliance for Human Research Protection, which is often critical of industry-academic ties, made the requests in a letter it sent Wednesday to the AMA and the journal, also known as JAMA."
FOR IMMEDIATE RELEASE March 27, 2009 AMA REQUESTS JOURNAL OVERSIGHT COMMITTEE REVIEW Statement attributable to: Joseph M. Heyman, M.D. AMA Board Chair "The American Medical Association is owner and publisher of the Journal of the American Medical Association (JAMA) and its specialty Archives journals. While we are ultimately responsible for these publications,…Read More
AHRP has sent a letter of complaint to the American Medical Association and the JAMA Oversight Committee calling for a public apology to Dr. Jonathan Leo by the AMA, a thorough investigation, the immediate suspension of the two editors involved, and a commitment to reviewing, clarifying and publishing JAMA’s editorial policies to protect against future violations of standards for professional conductRead More
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJRead More